This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Challenge Syner-G was contracted by a US PharmaceuticalCompany to help improve the quality of submission documentation generated during the manufacture of a Drug Substance intended for Phase II trials. The progress of the assignment was communicated to the client through weekly reports and regular virtual meetings.
Pharmaceuticalcompanies hold permission to market their products directly to consumers. The direct-to-consumer marketing companies for pharmaceuticals are increasingly moving online as it supports the digitisation of information, enabling patients to take control of their health.
The download contains detailed information on the providers and their services and solutions, alongside contact details to aid your purchasing or hiring decision. Prospects of clinical dose companies in contract marketing. Prospects of clinical dose companies in contract marketing.
For the most part, life science companies have a relatively good knowledge of what their audiences want and need from them. Unfortunately, this isn’t always convenient or aligned to the information and tactics they would choose to adopt in their communications. There is clear evidence of a customer-centric paradox. About the author.
Pharmaceutical detailing is the most time-tested marketing format in the medical content world. Old-timer sales reps should remember how pharmaceuticalcompanies reckoned face-to-face (F2F) visits with doctors as the most effective approach to achieving their sales targets. What is Pharmaceutical Detailing?
As this trend unfolds, it is vital to understand the benefits 5G brings, how it impacts healthcare communication , and how healthcare businesses can leverage it. 5G represents the 5th generation of cellular technology and is the gold standard in wireless communication today. In this article, we will explore these opportunities.
The surge in diseases is spurring demand for constructive treatment solutions, which is expected to boost the sales of injectable pharmaceuticalcompanies. Rapid absorption, faster drug action, lower risk of drug degradation by gastric secretion, and less concentration of the drug are driving the demand for injectable commercial doses.
RSV researchers at major pharmaceuticalcompanies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceuticalcompanies are pushing to develop drugs and vaccines for RSV with these populations in mind.
Pharmaceuticalcompanies are putting their trust in the immense potential this new generation of medicine has for treating individuals with rare genetic diseases, which currently affect an estimated 280 million patients worldwide. To learn more, please download the whitepaper below.
Allegedly, the inventor left the company, along with his proprietary recipe, and the product that the VSL #3 manufacturer has been making is different than the clinically tested product. Klaire Ther-Biotic – Another favorite high dose multi-strain probiotic of mine is made by Klaire Labs, and known as Ther-Biotic. You are worth it!
Linking events with the company’s broader content strategy will help regularly communicate more in-depth insights, and delivering content in new and engaging ways, such as gamification or extended reality, will draw in your audience. Dave Yates is a global product director at GSK Pharmaceuticals. About the interviewees.
If it’s a tight, complicated market, then doctors are going to be looking for the most compelling argument but lot of pharmaceuticalcompanies fall down by not really presenting their product in the best possible light.”. If your team is fully aware of their value, they feel confident communicating with customers. “I
To meet these challenges, pharmaceuticalcompanies are accelerating digital transformation and making manufacturing more responsive to changing market conditions while improving efficiency. Moreover, digitalization is increasingly encouraged by regulators as it improves compliance readiness and ensures greater supply chain resiliency.
To reduce the risk of cleanroom contamination, and in collaboration with a leading pharmaceuticalcompany, UV Medico has designed a breakthrough technology: The UV222 Booth. Download White Paper To download this white paper, complete the form below. You may unsubscribe from these ISPE communications at any time.
A landmark project for a major international pharmaceuticalcompany was the starting point for a series of follow-up projects in Switzerland and Germany. . Download White Paper. To download this white paper, complete the form below. Company Name. Company Type. Company Type. Leave this field blank.
These signals create communication and function within nerves and muscles, as the electrolytes move in or out of cells. Humic extract, the main ingredient, contains fulvate, which helps the cells in our gut better communicate with each other and bacteria. It also helps clear glyphosate out of the body.
He goes on to say that this might incentivize more pharmaceuticalcompanies to develop drugs that target the biology of aging. Download the full report to understand what to expect and how to align your strategies for success. Please check your email to download the Report. Evaluate the effects of COVID-19 on the sector.
Pharmaceuticalcompanies need to be prepared to answer the call for increased demand and supply into new markets, ensuring the proper resources and logistics framework are in place. Download to learn more. Please check your email to download the Whitepaper.
However, Amgen and other pharmaceuticalcompanies have been criticised when they opted to choose the drug’s dosage based on the MTD model, which is commonly used in dose-finding trials. Impact on the industry Veal says that for a lot of pharmaceuticalcompanies there is no “big drive to think about optimizing treatment” post-licensing.
GlobalData calculates these risk scores by evaluating several qualitative and quantitative factors to establish the quality of conditions and the level of stability of the market access environment encountered by pharmaceuticalcompanies in each country. Please check your email to download the Report.
Their spokesperson had this to say, “Patient safety is the priority for pharmaceuticalcompanies and regulators, and until there are validated non-animal alternatives that ensure patient safety of a new drug or vaccine, animal studies will continue to be the gold standard for preclinical studies.” However, the ABPI is more cautious.
This economic change impacts employment, income, industrial production, and more, and the pharmaceutical industry will not be exempt. While larger, more established pharmaceuticalcompanies may have the infrastructure and financial cushion to fall back on, SMEs need to tread carefully through these economic challenges.
Pharmaceutical sales in Brazil reached $17bn in 2021, according to GlobalData figures. Despite this, Brazil’s trade protectionist policies mean that there are few pharmaceuticalcompanies of international origin within the country. Please check your email to download the Whitepaper. by 2040 based on statistics from OECD.
Today, software companies know there is a growing market to meet demand for supply chain visibility platforms. The question for pharmaceuticalcompanies is how they can best deploy their data to make supply chains more efficient. Download the whitepaper on this page to find out more.
Of the world’s 20 largest pharmaceuticalcompanies, 17 have launched programmes tailored towards increasing medication access in low- and middle-income countries – up from just eight in 2010. Figure 1: Social media posts from pharmaceutical firms mentioning “environment”. A similar theme is evident in company filings.
With its highly educated, English-speaking workforce and high-quality medical facilities system, Singapore has attracted leading pharmaceuticalcompanies to open their regional headquarters in the city-state, including Novo Nordisk (Bagsvaerd, Denmark) and GSK. Please check your email to download the Report. By GlobalData.
After a long period of inactivity in RSV vaccine development , two pharmaceuticalcompanies are now approaching regulatory decisions for their RSV vaccines. GAVI has created a market for the pharmaceuticalcompanies to be able to develop enough doses for these LMIC markets. Evaluate the effects of COVID-19 on the sector.
Pharmaceuticalcompanies and organisations get access to large amounts of data related to patients, clinical trials, and regulatory affairs. The companies help to design, develop and scale marketing strategies to effectively transition into a digitalised future. Please check your email to download the Buyers Guide.
As a result, some pharmaceuticalcompanies are turning to third parties. As more companies rely on CROs and CDMOs, the criteria for selecting the right partner has also changed. To learn more about the factors biopharma companies are considering, download this whitepaper from Syngene here.
This could evolve into pharmaceuticalcompanies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles. By GlobalData. United Kingdom.
With better patient engagement having been proven to result in better health outcomes and reduced dropout rates, sponsors are increasingly recognising the vital importance of enrolling the right patients and communicating with them effectively. Please check your email to download the Whitepaper.
PAT, used correctly, should lead to better manufacturing processes and ultimately significant business benefits for the pharmaceuticalcompany. For more information download the paper below. Please check your email to download the Whitepaper.
The CLR is a great option for pharmaceuticalcompanies performing steam sterilisation in the drying chamber. This also gives us a bigger picture of the process and a deeper knowledge compared to other companies who maybe only provide a particular component to this application,” believes Kuchenbecker.
Provost added that while it is challenging for pharmaceuticalcompanies to create thermostable vaccines, this creates a severe issue for areas with high ambient temperatures where maintaining a protective cold chain is challenging because of a lack of infrastructure. Please check your email to download the Report.
Shoring these up will be a prerequisite for ushering in the age of decentralised pharmaceuticals. Pharmaceuticalcompanies need real-time visibility and insights into their supply chains to ensure patients are getting the therapies they need when they need them. Download the whitepaper on this page to find out more.
To keep within this limit, pharmaceuticalcompanies have had to pay rebates on their sales back to the NHS on all expenditures above the capped limit. Companies that choose not to take part in the voluntary scheme must partake in a statutory scheme. Please check your email to download the Report.
This could evolve into pharmaceuticalcompanies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles. By GlobalData. United Kingdom.
Shoring these up will be a prerequisite for ushering in the age of decentralised pharmaceuticals. Pharmaceuticalcompanies need real-time visibility and insights into their supply chains to ensure patients are getting the therapies they need when they need them. Download the whitepaper on this page to find out more.
It is also essential to evaluate the reliability of the company supplying the ingredient: do they provide sufficient communication and documentation? Download for a detailed copy of the results. Please check your email to download the Whitepaper. Will they ensure you are notified about any change to the product?
According to Baker Mackenzie , a law firm brand that specialises in a range of industries including healthcare and life sciences, IPOs allow pharmaceuticalcompanies to “access major global finance hubs and capital from a deep pool of investors around the world”. Please check your email to download the Report.
Pharmaceuticalcompany Genmab is entering a partnership with argenx to develop antibody therapies for oncology and immunology. This collaboration is being made to combine the companies’ capabilities to develop novel therapeutic antibodies with applications in the two disease areas. Evaluate the effects of COVID-19 on the sector.
Biostar Pharma chairman Dr Li Tang said this study approval was a milestone in the UTD1’s global development, and expressed an interest in partnering with other pharmaceuticalcompanies to bring the treatment to market. Download the full report to understand what to expect and how to align your strategies for success.
Explaining the rise of HPAPIs, Bruno Villa, CEO, MEDELPHARM believes the trend is a consequence of the increasing pressure on pharmaceuticalcompanies to develop drugs with improved efficiency and efficacy. To learn more about containment, download the whitepaper below. Please check your email to download the Whitepaper.
Celnova Pharma is an Argentina-based pharmaceuticalcompany that centres its work around rare diseases, oncology, central nervous system, diabetes and critical care. The company currently has operations in Argentina, Colombia, Chile, Peru, and Uruguay. Please check your email to download the Report.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content